KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) EBIT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.60%
Dec 31, 2025 6.26%
Sep 30, 2025 0.59%
Jun 30, 2025 2.72%
Mar 31, 2025 -12.94%
Dec 31, 2024 2.45%
Sep 30, 2024 -3.73%
Jun 30, 2024 -6.55%
Mar 31, 2024 -16.71%
Dec 31, 2023 -11.81%
Sep 30, 2023 -2.75%
Jun 30, 2023 -1.07%
Mar 31, 2023 -6.76%
Dec 31, 2022 -0.13%
Sep 30, 2022 1.75%
Jun 30, 2022 -4.21%
Mar 31, 2022 -0.71%
Dec 31, 2021 -1.50%
Sep 30, 2021 -1.21%
Jun 30, 2021 -19.04%
Mar 31, 2021 -2.38%
Dec 31, 2020 -0.25%
Sep 30, 2020 0.96%
Jun 30, 2020 2.27%
Mar 31, 2020 3.10%
Dec 31, 2019 7.02%
Sep 30, 2019 11.05%
Jun 30, 2019 7.08%
Mar 31, 2019 12.63%
Dec 31, 2018 14.95%
Sep 30, 2018 6.59%
Jun 30, 2018 12.81%
Mar 31, 2018 13.58%
Dec 31, 2017 15.59%
Sep 30, 2017 11.38%
Jun 30, 2017 11.17%
Mar 31, 2017 11.90%
Dec 31, 2016 16.42%
Sep 30, 2016 36.93%
Jun 30, 2016 12.31%
Mar 31, 2016 13.19%
Dec 31, 2015 13.74%
Sep 30, 2015 9.60%
Jun 30, 2015 6.48%
Mar 31, 2015 6.43%
Dec 31, 2014 5.37%
Sep 30, 2014 -1.80%
Jun 30, 2014 5.48%
Mar 31, 2014 0.64%